The effect of M.G ointment on reducing the severity of hemorrhoids

The efficacy of M.G Ointment containing essential oil of Myrtus and comparison of anti-hemorrhoid Ointment in reducing the severity of hemorrhoids and its complications

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220512054829N6

Enrollment

108

Registered

2025-08-12

Start date

2025-08-06

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid. K64.0

Interventions

Intervention 1: Intervention group: recipients of MG ointment with a high percentage of essential oil (10% essential oil). Intervention 2: Intervention group: recipients of MG ointment with a high per

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with grade 1 or 2 hemorrhoids

Exclusion criteria

Exclusion criteria: Thrombosed external hemorrhoids Strangulated internal hemorrhoids Fistula, fissure and abscess of anal Pregnancy Portal hypertension Renal failure Malignant diseases

Design outcomes

Primary

Measure	Time frame
Hemorrhoid severity. Timepoint: Study start, after two weeks of treatment. Method of measurement: Clinical assessment of disease symptoms based on VAS criteria by the surgeon.;Severity of Pain. Timepoint: Study start, after two weeks of treatment. Method of measurement: Based on the NRS-11 criterion.;Severity of Bleeding. Timepoint: Study start, after two weeks of treatment. Method of measurement: Clinical assessment and patient report.;Severe pain during bowel movements. Timepoint: Study start, after two weeks of treatment. Method of measurement: Based on the NRS-11 criterion.	—

Measure

Time frame

Hemorrhoid severity. Timepoint: Study start, after two weeks of treatment. Method of measurement: Clinical assessment of disease symptoms based on VAS criteria by the surgeon.;Severity of Pain. Timepoint: Study start, after two weeks of treatment. Method of measurement: Based on the NRS-11 criterion.;Severity of Bleeding. Timepoint: Study start, after two weeks of treatment. Method of measurement: Clinical assessment and patient report.;Severe pain during bowel movements. Timepoint: Study start, after two weeks of treatment. Method of measurement: Based on the NRS-11 criterion.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Akbari

Kashan University of Medical Sciences

akbari1350_h@yahoo.com+98 31 5558 9396

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026